| Financial Year |
March 31 2023 |
| Monetary Funds |
893,654,122.48 |
| Held-for-trading Financial Assets |
46,102,036.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
268,546,917.23 |
| Advances to Suppliers |
59,995,273.07 |
| Other Receivables |
47,635,333.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,290,708.26 |
| Inventories |
518,476,397.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,093,452.26 |
| Total Current Assets |
2,016,778,121.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
738,875,021.59 |
| Investment Properties |
-- |
| Fixed Assetes |
1,238,070,574.32 |
| Under-construction Projects |
43,173,581.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
235,740,774.38 |
| R&D expenses |
-- |
| Goodwill |
22,925,443.49 |
| Long-Term Deferred and Prepaid Expenses |
681,393.49 |
| Deferred Income Tax Assets |
15,640,681.75 |
| Other Non-Current Assets |
8,128,857.90 |
| Sub-Total of Non-Current Assets |
2,348,372,843.52 |
| Total Assets |
4,365,150,965.31 |
| Short-Term Loans |
215,838,642.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,246,259.25 |
| Accounts Payable |
116,458,729.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
53,769,534.47 |
| Taxes Payable |
13,062,920.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
48,989,240.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,999,320.48 |
| Other Current Liabilities |
2,588,489.07 |
| Sub-Total of Current Liabilities |
554,080,205.27 |
| Long-term Loans |
394,989,541.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,253,473.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
525,109,778.07 |
| Total Liabilities |
1,079,189,983.34 |
| Paid-In Capital(Or Share Stock) |
967,423,171.00 |
| Capital Surplus |
394,267,093.51 |
| Surplus Reserve |
259,316,056.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,064,344,102.33 |
| Minority Stockholder's Interest |
621,105,499.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,664,855,482.68 |
| Owner's Equity（Stockholder's Equity） |
3,285,960,981.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,365,150,965.31 |
